Back to News
Market Impact: 0.05
Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit
Source: GlobeNewswire
CEO Michael Halstead will participate in a fireside chat on September 23, 2026, at 9:00 a.m. EDT. The announcement provides no financial results, strategic update, or outlook, and is unlikely to affect valuation absent new disclosures at the event.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- All Iranian airlines to be 'shut down' from Wednesday, Bessent tells CNBC
- Taiwan benchmark Taiex rises to record intraday high as tech stocks advance
- AMD joins the $1 trillion club as chip rally surges - our AI Strategy saw it early
- Jamie Dimon says hyperscaler AI spending could hit $1 trillion next year
- Factbox-Key issues for this week’s Trump-Xi summit in Washington
- Latest Oil Market News and Analysis for Sept. 22
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- The $4.7 Trillion Bet: When Does AI Capex Become AI Revenue?
- Equity Research Automation Statistics: A 2026 Evidence Check